Medications
FDA approves oral Duvyzat for Duchenne muscular dystrophy
The U.S. Food and Drug Administration has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and older.
Mar 26, 2024
0
0